Individualized cancer treatments

A method of identifying whether an individual will benefit from the administration of a cancer therapeutic comprising:

• a. Analyzing a sample comprising cancer cells from a human individual to obtain a first gene expression profile comprising at least 10 genes from one of the chemosensitivity predictor sets of Table 4, 5 or 9;
• and
• b. comparing the first gene expression profile to a set of gene expression profiles that is capable of predicting responsiveness to a cancer therapy agent comprising the 10 genes from the chemosensitivity predictor set of Table 4, 5 or 9 to predict responsiveness to the cancer therapy agent;
• thereby identifying whether said individual would benefit from the administration of the cancer therapy agent.

A method of treating a human individual with ovarian cancer comprising:

• a. Analyzing a sample comprising cancer cells from the to obtain a first gene expression profile comprising at least 10 genes from one of the chemosensitivity predictor sets of Table 4, 5 or 9;
• b. comparing the first gene expression profile to a set of gene expression profiles that is predictive of responsivity to cancer therapy agents to identify whether the individual would be responsive to the cancer therapy agent, the set of gene expression profiles that is predictive of responsivity comprising the 10 genes from the chemosensitivity predictor set of Table 4, 5 or 9;
• and
• c. Administering to said individual an effective amount of a cancer therapy agent that was identified in step (b) as a cancer therapy agent to which the individual would respond;
• thereby treating the individual with ovarian cancer.